PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

類似資料

• Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
  著者:: Shepherd, Frances A., 等
  出版事項: (2017)
• Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
  著者:: Shepherd, Frances A., 等
  出版事項: (2013)
• Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection
  著者:: Tsao, Ming-Sound, 等
  出版事項: (2015)
• Neither sweet nor nutritious
  著者:: G.B. Hagelberg
  出版事項: (1993-01-01)
• Neither Sheep nor Goat
  出版事項: (1991)